p53 dysregulation is frequent in both ALL and AML, and loss of p53 function was previously reported to promote AML progression in a NUP98-HOXD13 mouse model, suggesting that it might contribute to NUP98-related leukemia [62,63,64]. This evidence concerns the gene HOXD13 and leukemia.